ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
0,005
0,00
(0,00%)
Geschlossen 22 Dezember 10:00PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,005
Gebot
0,005
Fragen
0,005
Volumen
-
0,00 Tagesbereich 0,00
0,005 52-Wochen-Bereich 0,01
Handelsende
0,005
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

BTI Neueste Nachrichten

Bioasis Provides Corporate Update and Announces Suspension of Operations

NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Provides Update on Business Operations

NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Announces AGM Results and Provides Update on Financial Position

NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc

NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022

NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders

NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc

NEW HAVEN, Conn., Dec. 19, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Technologies Inc. Announces Shareholder Webinar

NEW HAVEN, Conn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI) (OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc

NEW HAVEN, Conn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022

NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) --  BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.0050.0050.00500CS
4000.0050.0050.00500CS
12000.0050.0050.00500CS
26000.0050.0050.00500CS
52000.0050.010.00595670.00571757CS
156-0.245-980.250.310.005356640.05317323CS
260-0.185-97.36842105260.190.70.005392100.1752188CS

BTI - Frequently Asked Questions (FAQ)

What is the current BiOasis Technologies share price?
The current share price of BiOasis Technologies is $ 0,005
What is the 1 year trading range for BiOasis Technologies share price?
BiOasis Technologies has traded in the range of $ 0,005 to $ 0,01 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GNFIGenifi Inc
$ 0,015
(200,00%)
4k
GHR.HGolden Harp Resources Inc
$ 0,10
(185,71%)
2,73k
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
2k
NICKNickelex Resource Corporation
$ 0,01
(100,00%)
1,1k
GAR.HGreen Arrow Resources Inc
$ 0,045
(80,00%)
1.000
CBAChampion Bear Resources Ltd
$ 0,015
(-62,50%)
101k
NIKL.HGK Resources LTD
$ 0,045
(-50,00%)
1.000
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
3,34M
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
106,09k
COOOstrom Climate Solutions Inc
$ 0,05
(-50,00%)
109,5k
QNCQuantum Emotion Corp
$ 0,435
(26,09%)
7,32M
GXUGoviEx Uranium Inc
$ 0,055
(10,00%)
4,68M
FUUF3 Uranium Corp
$ 0,25
(6,38%)
3,64M
AUUAALUULA Composites Inc
$ 0,05
(0,00%)
3,63M
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
3,34M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock